share_log

Finch Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Chief Executive Officer Blischak Matthew P.

Finch Therapeutics | 4/A:持股變動聲明(修正)-首席執行官 Blischak Matthew P.

SEC announcement ·  2023/06/23 16:30
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息